Drugs / Weiyang Yuping Fang
Weiyang Yuping Fang
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04522726 | Oct 2020 → Sep 2024 | intermittent asthma | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Weiyang Yuping Fang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04522726 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Weiyang Yuping fang is a combination of the classic ancient Yuping dispersion used to prevent qi deficiency and susceptibility and Bushen Naqi granules optimized formated by...” NCT04522726 ↗ |
| Route | Oral | “Weiyang Yupingfang Granules orally” NCT04522726 ↗ |